Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KDT-3594 drug-drug interaction study with itraconazole in healthy Japanese men
jRCT2071250055Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of matsupexole and itraconazole in Parkinson's disease (PD), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Plasma pharmacokinetic profile of KDT-3594 (unchanged form). Started Sep 2025; status: completed.
02
Drugs
matsupexoleitraconazole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2071250055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250055.